Monashee Investment Management LLC Dyne Therapeutics, Inc. Transaction History

Monashee Investment Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$23.65 - $35.63 $2.01 Million - $3.03 Million	-85,000 Reduced 50.0%	85,000 $3 Million
Q1 2024 May 14, 2024	BUY	$13.06 - $29.18 $2.22 Million - $4.96 Million	170,000 New	170,000 $4.83 Million
Q4 2022 Feb 09, 2023	SELL	$9.37 - $13.8 $714,752 - $1.05 Million	-76,281 Reduced 38.14%	123,719 $1.43 Million
Q3 2022 Nov 01, 2022	SELL	$7.2 - $15.17 $860,659 - $1.81 Million	-119,536 Reduced 37.41%	200,000 $2.54 Million
Q2 2022 Aug 12, 2022	BUY	$4.36 - $10.5 $173,667 - $418,236	39,832 Added 14.24%	319,536 $2.2 Million
Q1 2022 May 12, 2022	BUY	$6.52 - $12.27 $1.2 Million - $2.26 Million	184,404 Added 193.5%	279,704 $2.7 Million
Q4 2021 Feb 07, 2022	BUY	$11.89 - $16.07 $1.13 Million - $1.53 Million	95,300 New	95,300 $1.13 Million
Q4 2020 Feb 11, 2021	SELL	$16.81 - $23.94 $1.81 Million - $2.58 Million	-107,735 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$20.0 - $23.9 $2.15 Million - $2.57 Million	107,735 New	107,735 $2.18 Million

210

102M

234K

238K

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.54B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.